Cronos Group Inc. (CRON): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$4.45M

Year ended 2025-12-31

$5.36M

Trailing 12 months to 2026-06-30

-30.3%

3-year compound annual growth

2017-12-31 R&D Expense (USD) 2025-12-31

Period ended	R&D Expense	Change YoY	Source filing
2025-12-31	$4.45M	+5.2%	2026-02-26, From 2025-01-01
2024-12-31	$4.23M	-27.6%	2026-02-26, From 2024-01-01
2023-12-31	$5.84M	-55.5%	2026-02-26, From 2023-01-01
2022-12-31	$13.13M	-39.9%	2025-02-27, From 2022-01-01
2021-12-31	$21.84M	n/c	2024-02-29, From 2021-01-01
2020-12-31	$20.37M	+67.6%	2023-02-28, From 2020-01-01
2019-12-31	$12.15M	+570.1%	2022-03-01, From 2019-01-01
2018-12-31	$1.81M	n/a	2021-02-26, From 2018-01-01
2017-12-31	$0	n/a	2020-03-30, From 2017-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	R&D Expense	Change YoY
Cronos Group Inc. (CRON)	2025-12-31	$4.45M	+5.2%
Natural Alternatives International Inc (NAII)	2025-06-30	$1.80M	-5.3%
Niagen Bioscience, Inc. (NAGE)	2025-12-31	$6.33M	+5.2%
Mannatech Inc (MTEX)	2025-12-31	$800.0K	+14.3%
Leef Brands Inc. (LEEEF)	2025-12-31	$19.7K	+3.8%
Cyanotech Corp (CYAN)	2025-03-31	$449.0K	-34.8%
Tilray Brands, Inc. (TLRY)	2026-05-31	$361.0K	+27.1%
USANA Health Sciences Inc (USNA)	2026-01-03	$10.69M	-7.6%
Bon Natural Life Ltd (BON)	2025-09-30	$754.2K	-53.5%

Compare CRON, NAII, NAGE, MTEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗